Alivexis, Inc. (“Alivexis”), a computation-driven drug discovery company, will present at the ACS Spring Conference, to be held March 22-26 in Atlanta, Georgia. The presentation is scheduled for Tuesday, March 24 at in Room C209 at George World Congress Center.

The symposium, entitled “Bridging Physics and AI: New Frontiers in Molecular Recognition: Integrative Modeling for Binding & Beyond” will feature a presentation by S. Roy Kimura, Alivexis co-founder and CEO, introducing ModBind_dG, a proprietary fast and accurate simulation-based method for prediction of absolute free energies of binding.

Alivexis’ presentation details are as follows:
Event: ACS Spring
Presentation Date/Time: Tuesday, March 24 16:15-16:45 (EST)
Venue: C209 Georgia World Congress Center
Presenter: S. Roy Kimura, Co-founder and CEO
Title: ModBind_dG, a simulation-based absolute predictor of free energy of binding based on population reweighting

Alivexis to Present at ACS Spring Conference(PDF)